Sequoia co-leads $30 million investment in MedGenome’s research and diagnostics testing https://t.co/iaGEABVFCN via @VentureBeat
— The Propell Group (@ThePropellGroup) September 4, 2017
#healthtech
Sequoia co-leads $30 million investment in MedGenome’s research and diagnostics testing https://t.co/iaGEABVFCN via @VentureBeat
— The Propell Group (@ThePropellGroup) September 4, 2017
#healthtech